StockData
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30

Cencora, Inc.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$340.00−0.92 (-0.27%)

Close on Oct 19, 2026

Market cap
$65.94B
P/E (TTM)
25.2
Dividend yield
0.65%

Cencora, Inc. cash flow statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
4.0%
Operating margin
0.9%
Net margin
0.8%
Return on equity, FY2025
144.3%

Financial strength

Current ratio
0.93
Debt to equity
3.84
Debt to assets
14.0%
Cash to current liabilities
4.8%

Valuation

P/E ratio
25.2
Price to sales
0.20
Price to book
21.61
Dividend yield
0.65%